相关实验视频

Updated: Jul 6, 2026

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols

Published on: January 2, 2013

在败血症患者中,使用Seraph-100的血液输液可以去除病原体并改善临床结果

Antonio Lacquaniti¹, Antonella Smeriglio², Fabrizio Ceresa³

¹Nephrology and Dialysis Unit, Papardo Hospital, 98158, Messina, Italy.

Scientific reports

|May 21, 2025

概括

在心脏手术后的严重败血症患者中,Seraph-100血液输液有效降低了细菌负载和炎症标志物. 这种治疗改善了临床结果,包括减少了ICU停留时间和急性损伤,需要替代疗法.

科学领域:

关键护理医学关键护理医学
传染性疾病传染性疾病
腎臟病學 (nephrology) 是一種醫學專業.

背景情况:

感染性内心炎的心脏手术后的败血症带来了重大挑战.
血液输血 (HP) 是一种新兴的败血症治疗方式.
在这种患者群体中,像Seraph-100这样的特定HP设备的有效性需要进一步调查.

研究的目的:

评估Seraph-100输血在感染性内心炎心脏手术后入院ICU的败血症患者的有效性.
评估Seraph-100 HP对病原体负载,炎症标志物和临床结果的影响.

主要方法:

一项前性研究涉及13名接受Seraph-100 HP治疗的败血症患者和15名非HP治疗患者的对照组.
在HP前后使用定量PCR (∆Cq值) 评估病原体负载.
生物标志物 (前素,C反应蛋白,乳酸盐) 和临床结果 (ICU停留,急性损伤 (AKI),替代疗法 (RRT) 需求) 被监测.

主要成果:

赛拉夫-100HP显著降低了细菌负载 (平均∆Cq为4.6±2.4),经血培验证实.
观察到甲,C反应蛋白和乳酸盐的显著下降.
在Seraph-100组中,需要RRT的AKI发病率降低 (15%与对照组的40%相比),血管压缩剂使用减少,ICU停留时间缩短.

结论:

塞拉夫-100血 perfusion 是一个安全和有效的辅助治疗严重病患者的败血症的心脏外科手术后的IE.
该设备展示了病原体去除能力,并改善了关键的临床参数,包括功能和整体恢复.
这种方法提供了一种有希望的策略,以减轻与败血症相关的并发症,并减少医疗保健资源利用率.

关键词:

艾基 (AKI) 是一个人.血 perfusion 输血输血输血输血输血输血输血输血在ICU停留.败血症这是一种败血症.谢拉夫-100名谢拉夫100名

更多相关视频

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

相关概念视频

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...

Hemodialysis I: Introduction

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...